Can Conservatives Afford to Be Nice Anymore? By Taylor

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone PoemStone #36760
221
Can Conservatives Afford to Be Nice Anymore?
By Taylor Lewis < >

Tucker Carlson's famous Fox News monologue about the moral pitfalls of unquestioned free-market worship continues to cause aftershocks.

The right has long had the debate on just how healthy individual autonomy is for societal well-being. But the combination of Donald Trump's nationalist vision overtaking the Republican Party and the Left molting its concern for solidarity in favor of radically subjective individualism has raised anew questions about what broad-c conservatives are willing to accept in a well ordered society.

For example, are drag reading hours in public libraries really appropriate for kids?

Cross-dressing storytime is what set New York Post op-ed editor Sohrab Ahmari off in a scathing attack on one right-wing writer. In First Things, which has latterly become a kind of authorial billet for non-traditional traditionalistic conservatives, Ahmari takes issue with what he calls "David French-ism," which takes its name from National Review essayist David French.

Who is David French, and why is he lucky enough to get his own ideology?

Ahmari treats French like a synecdoche for all hail-fellow-well-met conservative types who think the Left will leave them be with their personal religious beliefs, even if they're viewed as bigoted. Ahmari contends that French and other libertarian-friendly conservatives believe that "the institutions of a technocratic market society are neutral zones that should, in theory, accommodate both traditional Christianity and the libertine ways and paganized ideology of the other side."

Ahmari is not so dewy-eyed. He knows the score, and it's heavily weighed against the side of conservative Christians. A converted integralist and recent recruit of the "politics as war and enmity" vision, Ahmari thinks rapprochement with a cultural left that showers preteen strippers with dollar bills is unrealistic. Instead, he'd rather bring a sword, capturing the state to carve out a permanent place for the faithful. In his own words, Ahmari wants to fight the "culture war with the aim of defeating the enemy and enjoying the spoils in the form of a public square re-ordered to the common good and ultimately the Highest Good."

French, in Ahmari's dichotomy, wishes for only a respectful counterpoise to liberalism's ever encroaching reach into private and public life. Ahmari forthrightly wants to beat it back into submission.

Ahmari correctly points out that French is actually a classical liberal rather than a conservative. He goes farther, not just accusing broad liberalism of undercutting Christian dogma, but also assailing French as a naïf who thinks vivre et laisser vivre is a worldview acceptable to the Left.

We already know there's more than a bit of truth to the idea that the Left won't let Christian beliefs on sex and morality stand in the public square. Just see how Vice President Pence is talked about the in media for his orthodox beliefs on sexual relations or, alternatively, how conservative judicial nominees are treated by congressional Democrats.

Christian proscriptions on sexual debauchery make the belief system inimical to a Left that views autonomy and non-judgment as the pinnacle of human flourishing. And as long as such a perverse liberalism is engrafted in the upper strata of American culture — Hollywood, academia, the theater, the media — then traditionalists will continue to be marginalized, eventually to the point of public extinction, where the Bible becomes a samizdat.

Ahmari's urgent sense of the Left's no-quarter approach to the culture war is important. It's reminiscent of Rod Dreher's blog-writing years ago, warning that winsomeness won't save Christians from the liberal inquisition.

The problem with Ahmari's blistering critique isn't his portentous prognostication — it's the target. David French has responded, and the reply makes Ahmari's volley feel off the mark. French isn't an overweight armchair warrior composing polemics from a chic Washington, D.C. corner office, his greasy beard glistening with sweat after walking a block and a half to pick up lunch because his intern is out. David French is the ideal kind of American citizen: a patriot who served his country and now uses his profession to serve God and the Constitution's First Amendment. His heart was even big enough to adopt a little girl from Ethiopia, for Pete's sake.

He's also done the real work that many defenders of the faith have ever done only in writing: he's tried actual cases defending religious liberty. And he's won more than just legal victories. "I and lawyers I was proud to work with didn't just win these court cases, we persuaded left-dominated institutions to turn back from repressive illiberalism and recommit to religious pluralism," French wrote in rejoinder to Ahmari.

It's tough to think of a worse target for Ahmari's jeremiad against babe-in-the-woods conservatism. There are indeed prominent thinkers and writers who espouse the comity-laden message French does but who aren't equipped for the no-holds-barred culture war that's escalating. Ahmari chose the wrong figure to personify naïveté.

That's not to say his essay doesn't perform its own service. Ahmari has lent his voice to a growing sect in conservatism. The question of how much liberalism a society can endure before losing its stability and historic bearings to antinomian solipsism is one rarely considered by French and his high-minded ilk. As Tim Carney demonstrates in his recent book, Alienated America, the country's societal capital continues to be spent at the expense of a no-gods-before-me autonomy.

More importantly, Ahmari doesn't shy away from what I call the camp-of-the-saints dilemma. Jean Raspail's racist yet prescient novel grapples with the existential conflict between survival and principle. How do you keep your society intact when your own deeply held beliefs suggest a suicidal satyagraha? Put differently, how do Christians love their neighbor when their neighbors hate their guts and openly wish to reduce them to second-class citizens in the public square?

Does it ever become necessary to fight back, and be like Isaac in Manhattan and "get some bricks and baseball bats and really explain things to them"?

This is the hardest question post-liberal types like Ahmari have to answer. What it comes down to is force: how willing is a conservative to use the government's monopoly on violence to his own greater ends?

With the Left taking ever greater liberty to shut down Catholic adoption agencies, penalize Christian charities, and even turn Christians into workplace liabilities, sooner or later, conservatives of all camps will have to make a decision. It's either the cheerful sidelines or the fray. And if it's the fray, what does a lasting victory look like?

Ahmari has taken a step to answer that pressing question. French and his sympathizers would be wise to take a more realistic view of the public square, which increasingly is unwelcome to them.


Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 3

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 2

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 2

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading

Top 5 Most Recently Viewed Articles

Big Screen Entertainment Group Unveils Big Screen Capital Fund

Updated Category News Views 138

Introducing Big Screen Capital Big Screen Entertainment Group (OTC:BSEG) has just announced the launch of its new funding subsidiary, Big Screen Capital. This exciting development is set to finance a range of creative projects, including the establishment of the Big Film Fund, as well as two upcoming films and advancements in medical technology. With this strategic move,...

Continue Reading
Air Products Faces Integrity Challenges: A Call for Change

Updated Category News Views 129

Understanding the Recent Calls for Change at Air Products Mantle Ridge has taken a bold step by issuing a shareholder letter that highlights critical concerns regarding Air Products and Chemicals, Inc. The organization, which owns approximately $1.3 billion in shares of Air Products, has pointed out various omissions and misleading statements from the company’s...

Continue Reading
Navigating Key Market Shifts in H2 2026: A Crucial Period

Updated Category News Views 5

The Intensity of Mid-2026: Traders Brace for Impact Traders are steeling themselves for July's rollercoaster of central bank decisions. This isn't just another season; it's a potential market earthquake. When you've got the European Central Bank, Bank of England, and Federal Reserve all signaling rate announcements within days, it's time to pay more than a little...

Continue Reading
Summary of Recent Extraordinary General Meeting Outcomes

Updated Category News Views 158

Results of Extraordinary General Meeting Announcement German High Street Properties A/S is pleased to present the results from the extraordinary general meeting that took place. This meeting marks a significant moment for the company and its shareholders as they come together to discuss essential matters affecting the company's future. Date and Purpose of the Meeting The...

Continue Reading
Tectonic Therapeutics Advances TX45 for Heart Failure Treatment

Updated Category News Views 166

Tectonic Therapeutics Advances TX45 for Heart Health Tectonic Therapeutic, Inc. (NASDAQ: TECX), an innovative biotechnology company, has announced promising outcomes from its Phase 1a trials, which could lead to significant progress in treating Group 2 Pulmonary Hypertension in patients experiencing Heart Failure with Preserved Ejection Fraction (PH-HFpEF). The results...

Continue Reading